Lam Research
LRCX
$343.84
+3.45%
Lam Research Corp is a leading supplier of semiconductor wafer fabrication equipment, specializing in deposition and etch processes essential for manufacturing advanced chips. The company holds the top market share in etch and the second position in deposition, serving major chipmakers like TSMC, Samsung, Intel, and Micron. The current investor narrative centers on the AI-driven semiconductor supercycle, with Lam positioned as a critical enabler of AI chip production, evidenced by record revenue and a bullish outlook. However, recent market volatility and concerns about overvaluation in AI-related sectors have introduced debate about the sustainability of its growth trajectory.…
LRCX
Lam Research
$343.84
Related headlines
Investment Opinion: Should I buy LRCX Today?
Rating: Buy. Lam Research is a high-quality growth stock with a Strong Buy consensus and an average target price of $368.94, implying 11% upside. The thesis is supported by accelerating revenue growth of 23.8% YoY, a net margin of 31.2%, and a forward P/E of 28.8x, which is reasonable for the growth rate. The company's dominant position in etch and deposition makes it a critical beneficiary of the AI infrastructure build-out.
Sign up to view all
LRCX 12-Month Price Forecast
The AI-driven semiconductor supercycle is a powerful tailwind for Lam Research, given its critical role in etch and deposition. The company's financial performance is exceptional, with accelerating growth and high margins. However, the valuation is stretched, and the stock's high beta makes it susceptible to sharp corrections. I would upgrade my stance if revenue growth accelerates above 25% and the forward P/E stays below 30x. I would downgrade if AI capex shows signs of slowing or if margins deteriorate.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Lam Research's 12-month outlook, with a consensus price target around $368.94 and implied upside of +7.3% versus the current price.
Average Target
$368.94
0 analysts
Implied Upside
+7.3%
vs. current price
Analyst Count
—
covering this stock
Price Range
$290 - $500
Analyst target range
Lam Research is covered by 31 analysts, with a consensus recommendation of 'Strong Buy' and a mean rating of 1.46 (where 1 is Strong Buy and 5 is Sell). The average price target is $368.94, implying an upside of 11.0% from the current price of $332.36. The distribution is overwhelmingly bullish, with no Sell ratings and a majority of Buy or Overweight ratings, reflecting strong conviction in the company's growth prospects. The target price range spans from $290.00 (low) to $500.00 (high), indicating a wide dispersion in expectations. The high target of $500 implies a 50.4% upside, likely assuming continued AI-driven demand and market share gains, while the low target of $290 suggests a 12.8% downside, possibly pricing in a cyclical downturn or margin pressure. Recent institutional actions have been uniformly positive, with firms like Needham, Stifel, and Morgan Stanley reiterating Buy or Overweight ratings in July 2026, signaling sustained confidence in Lam's outlook.
Bulls vs Bears: LRCX Investment Factors
Lam Research presents a compelling bull case driven by accelerating revenue growth, exceptional profitability, and a dominant position in AI-enabling semiconductor equipment. The bear case centers on valuation risk, with a trailing P/E of 71x and high beta exposing the stock to sharp corrections. Currently, the bull side has stronger evidence given the 23.8% revenue growth and 31.2% net margin, but the key tension is whether the market's growth expectations are sustainable. If AI infrastructure spending continues to expand, the stock has upside to analyst targets; however, any sign of demand normalization could trigger a de-rating, making the valuation the pivotal factor.
Bullish
- Revenue growth accelerating to 23.8% YoY: Q3 FY2026 revenue reached $5.84B, up 23.8% from $4.72B a year ago, with sequential acceleration from prior quarters. This is driven by AI infrastructure demand for advanced etch and deposition tools, positioning Lam as a key enabler of the AI supercycle.
- Exceptional profitability with 31.2% net margin: Net income of $1.83B in Q3 FY2026 translates to a 31.2% net margin, up from 28.2% a year ago. Gross margin expanded to 49.8% and operating margin to 35.0%, reflecting strong pricing power and operational leverage.
- Strong balance sheet and cash generation: Debt-to-equity is a low 0.33, current ratio is 2.63, and TTM free cash flow is $6.45B. This financial strength supports continued investment in R&D and shareholder returns, with a payout ratio of 17.5%.
- Analyst consensus is Strong Buy with 11% upside: 31 analysts rate LRCX a Strong Buy (mean 1.46), with an average price target of $368.94, implying 11.0% upside from $332.36. No Sell ratings and recent reiterations from Needham, Stifel, and Morgan Stanley underscore confidence.
Bearish
- Trailing P/E of 71x is historically stretched: The trailing P/E of 71.0x is near the top of its historical range (8.9x-71.0x) and 184% above the industry average of ~25x. This premium leaves little room for error; any growth disappointment could trigger multiple compression.
- High beta of 1.865 amplifies market swings: With a beta of 1.865, LRCX is highly sensitive to market movements. The stock has already experienced a -41.8% drawdown from its 52-week high of $438.50, illustrating the volatility inherent in semiconductor names.
- Recent price pullback and 'sell the news' risk: After hitting $438.50 in June 2026, the stock fell to $332.36, a -24% decline. News of Samsung's strong earnings triggered a 'sell the news' event in July, suggesting the market may be questioning AI-related valuations.
- Cyclicality of semiconductor equipment demand: Lam's revenue is tied to the cyclical capex of chipmakers. Memory exposure (DRAM/NAND) adds volatility; a downturn in memory pricing or a pause in AI infrastructure spending could sharply reduce orders.
LRCX Technical Analysis
Lam Research is in a powerful long-term uptrend, with the stock up 209.5% over the past year, dramatically outperforming the S&P 500's 20.4% gain. The current price of $332.36 sits at 75.8% of its 52-week range (low of $94.11, high of $438.50), indicating the stock is trading closer to its highs but has pulled back from the peak. This positioning suggests strong momentum but also potential overextension, as the stock has experienced a significant drawdown of -41.8% from its high, highlighting the volatility inherent in the semiconductor sector.
Beta
1.86
1.86x market volatility
Max Drawdown
-41.8%
Largest decline past year
52-Week Range
$94-$439
Price range past year
Annual Return
+245.5%
Cumulative gain past year
| Period | LRCX Return | S&P 500 |
|---|---|---|
| 1m | +9.7% | +4.0% |
| 3m | +25.8% | +5.3% |
| 6m | +43.2% | +12.6% |
| 1y | +245.5% | +20.1% |
| ytd | +85.8% | +13.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
LRCX Fundamental Analysis
Lam Research's revenue trajectory is robustly accelerating, with the most recent quarter (Q3 FY2026) posting revenue of $5.84 billion, a 23.8% year-over-year increase. This marks a clear acceleration from the prior year's quarters, where revenue grew from $4.72 billion in Q3 FY2025 to $5.84 billion, reflecting a sequential growth trend. The growth is driven by both system sales ($3.73 billion) and customer support ($2.11 billion), with the AI infrastructure build-out fueling demand for advanced etch and deposition tools. The company's profitability is exceptional, with a net income of $1.83 billion in the latest quarter, translating to a net margin of 31.2%, up from 28.2% a year ago. Gross margin expanded to 49.8% from 49.0%, and operating margin reached 35.0%, indicating strong pricing power and operational leverage. Lam's balance sheet is solid, with a debt-to-equity ratio of 0.33 and a current ratio of 2.63, providing ample liquidity. Free cash flow for the trailing twelve months stands at $6.45 billion, and the company generated $1.14 billion in operating cash flow in the latest quarter, comfortably covering capital expenditures and dividends. The return on equity is an impressive 58.3%, reflecting efficient capital deployment and shareholder value creation.
Quarterly Revenue
$5.8B
2026-03
Revenue YoY Growth
+23.8%
YoY Comparison
Gross Margin
49.8%
Latest Quarter
Free Cash Flow
$6.5B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is LRCX Overvalued?
Given Lam's strong profitability, the trailing P/E ratio of 71.0x is the primary valuation metric, but the forward P/E of 28.8x is more indicative of expected earnings growth. The wide gap between trailing and forward P/E implies the market anticipates substantial earnings growth, which is supported by analyst estimates of $17.30 EPS for the next fiscal year. Compared to the industry average, Lam trades at a significant premium, with a P/E of 71.0x versus the semiconductor industry average of around 25x, representing a 184% premium. This premium is justified by Lam's superior growth and profitability, as evidenced by its 31.2% net margin and 23.8% revenue growth, which outpace industry norms. Historically, Lam's P/E has ranged from 8.9x to 71.0x over the past few years, with the current trailing P/E near the top of that range. This suggests the market is pricing in optimistic expectations for continued AI-driven growth, and any disappointment could lead to multiple compression.
PE
71.0x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 9x~35x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
59.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financial risks include a high trailing P/E of 71x, which leaves the stock vulnerable to multiple compression if earnings growth slows. While the balance sheet is solid with a debt-to-equity of 0.33 and current ratio of 2.63, the company's profitability is tied to the cyclical semiconductor industry. Revenue concentration in a few large customers (TSMC, Samsung, Intel, Micron) and memory exposure increase earnings volatility, as seen in the -41.8% max drawdown from the 52-week high. Free cash flow of $6.45B TTM provides a cushion, but a downturn could pressure margins and cash generation.